R&D ability
In 2023, research expenditure accounted for 24.00% of revenue with cumulative spending on R&D exceeding $56 million. Our laboratory capabilities include isolation and identification of pathogens, primary cell culture, virus modification and cell line establishment, production process studies, and molecular immunological experiments.
Shen Lian Biomedical has a core R&D team composed of leading talents, including senior industry experts, technical experts, and returned Ph.D.s from abroad. The company employs 363 staff, with 95 people dedicated to R&D. Among the R&D staff, 45% hold Master's degrees and 26% have Doctorates.
At the same time, Shen Lian Biomedical pays great attention to recruiting diversified talents from top universities all over the world, with professional backgrounds covering biology, chemistry, medicine, engineering, pharmacy and other disciplines.
